WO2008156614A3 - Imidazopyrazines as protein kinase inhibitors - Google Patents
Imidazopyrazines as protein kinase inhibitors Download PDFInfo
- Publication number
- WO2008156614A3 WO2008156614A3 PCT/US2008/007295 US2008007295W WO2008156614A3 WO 2008156614 A3 WO2008156614 A3 WO 2008156614A3 US 2008007295 W US2008007295 W US 2008007295W WO 2008156614 A3 WO2008156614 A3 WO 2008156614A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compounds
- imidazopyrazines
- protein kinase
- kinase inhibitors
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08768351A EP2170892A2 (en) | 2007-06-14 | 2008-06-11 | Imidazopyrazines as protein kinase inhibitors |
CA2690557A CA2690557A1 (en) | 2007-06-14 | 2008-06-11 | Imidazopyrazines as protein kinase inhibitors |
MX2009013729A MX2009013729A (en) | 2007-06-14 | 2008-06-11 | Imidazopyrazines as protein kinase inhibitors. |
CN200880101960A CN101772500A (en) | 2007-06-14 | 2008-06-11 | Imidazopyrazines as protein kinase inhibitors |
JP2010512177A JP2010529195A (en) | 2007-06-14 | 2008-06-11 | Imidazopyrazine as an inhibitor of protein kinase |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94399907P | 2007-06-14 | 2007-06-14 | |
US60/943,999 | 2007-06-14 | ||
US98793207P | 2007-11-14 | 2007-11-14 | |
US60/987,932 | 2007-11-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008156614A2 WO2008156614A2 (en) | 2008-12-24 |
WO2008156614A3 true WO2008156614A3 (en) | 2009-02-12 |
Family
ID=40002934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/007295 WO2008156614A2 (en) | 2007-06-14 | 2008-06-11 | Imidazopyrazines as protein kinase inhibitors |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2170892A2 (en) |
JP (1) | JP2010529195A (en) |
CN (1) | CN101772500A (en) |
AR (1) | AR066958A1 (en) |
CA (1) | CA2690557A1 (en) |
CL (1) | CL2008001745A1 (en) |
MX (1) | MX2009013729A (en) |
PE (1) | PE20090365A1 (en) |
TW (1) | TW200911811A (en) |
WO (1) | WO2008156614A2 (en) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2756759C (en) | 2009-04-16 | 2017-11-07 | Joaquin Pastor Fernandez | Imidazopyrazines for use as kinase inhibitors |
TW201107329A (en) * | 2009-07-30 | 2011-03-01 | Oncotherapy Science Inc | Fused imidazole derivative having ttk inhibitory action |
US8993535B2 (en) | 2009-09-04 | 2015-03-31 | Merck Sharp & Dohme Corp. | Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors |
NZ599597A (en) | 2009-10-30 | 2013-05-31 | Janssen Pharmaceutica Nv | IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS |
AR080754A1 (en) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | IMIDAZO DERIVATIVES (1,2-A) PIRAZINA AND ITS USE AS PDE10 INHIBITORS |
EP2576560B1 (en) * | 2010-06-01 | 2015-09-30 | Bayer Intellectual Property GmbH | Substituted imidazopyrazines |
DK2630259T3 (en) * | 2010-10-20 | 2015-07-06 | Univ Bordeaux | SIGNATURES OF CLINICAL OUTCOME In gastrointestinal stromal tumors AND METHOD FOR THE TREATMENT OF gastrointestinal stromal tumors |
EP2444084A1 (en) | 2010-10-21 | 2012-04-25 | Centro Nacional de Investigaciones Oncológicas (CNIO) | Use of PI3K inibitors for the treatment of obesity |
WO2012052745A1 (en) | 2010-10-21 | 2012-04-26 | Centro Nacional De Investigaciones Oncológicas (Cnio) | Combinations of pi3k inhibitors with a second anti -tumor agent |
US20140187548A1 (en) * | 2010-12-17 | 2014-07-03 | Bayer Intellectual Property Gmbh | 6 substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders |
US8673905B2 (en) * | 2011-03-17 | 2014-03-18 | Hoffmann-La Roche Inc. | Imidazo pyrazines |
CN103732589B (en) | 2011-05-25 | 2016-03-30 | 百时美施贵宝公司 | Can be used as the sulphonamide of the replacement of anti-apoptotic BCL inhibitor |
MX344600B (en) | 2011-06-27 | 2016-12-20 | Janssen Pharmaceutica Nv | 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES. |
RU2657540C2 (en) | 2012-06-26 | 2018-06-14 | Янссен Фармацевтика Нв | Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4]triazolo[4,3-a]quinoxaline compounds and pde 10 inhibitors for use in treatment of neurological or metabolic disorders |
RU2667058C2 (en) | 2012-07-09 | 2018-09-14 | Янссен Фармацевтика Нв | Inhibitors of phosphodiesterase 10 enzyme |
CU24389B1 (en) | 2014-01-13 | 2019-04-04 | Aurigene Discovery Tech Ltd | BICYCLIC HETEROCICLYL COMPOUNDS AS IRAK4 INHIBITORS |
US9493442B2 (en) | 2014-02-13 | 2016-11-15 | Incyte Corporation | Cyclopropylamines as LSD1 inhibitors |
PL3105218T3 (en) | 2014-02-13 | 2020-03-31 | Incyte Corporation | Cyclopropylamines as lsd1 inhibitors |
WO2015123437A1 (en) | 2014-02-13 | 2015-08-20 | Incyte Corporation | Cyclopropylamines as lsd1 inhibitors |
LT3105226T (en) | 2014-02-13 | 2019-11-11 | Incyte Corp | Cyclopropylamines as lsd1 inhibitors |
WO2016007722A1 (en) | 2014-07-10 | 2016-01-14 | Incyte Corporation | Triazolopyridines and triazolopyrazines as lsd1 inhibitors |
WO2016007727A1 (en) | 2014-07-10 | 2016-01-14 | Incyte Corporation | Triazolopyridines and triazolopyrazines as lsd1 inhibitors |
TW201613925A (en) | 2014-07-10 | 2016-04-16 | Incyte Corp | Imidazopyrazines as LSD1 inhibitors |
WO2016007731A1 (en) | 2014-07-10 | 2016-01-14 | Incyte Corporation | Imidazopyridines and imidazopyrazines as lsd1 inhibitors |
EP3277689B1 (en) | 2015-04-03 | 2019-09-04 | Incyte Corporation | Heterocyclic compounds as lsd1 inhibitors |
SG10202001219UA (en) | 2015-08-12 | 2020-03-30 | Incyte Corp | Salts of an lsd1 inhibitor |
PE20190377A1 (en) | 2016-04-22 | 2019-03-08 | Incyte Corp | FORMULATIONS OF AN LSD INHIBITOR 1 |
EP3548035A4 (en) | 2016-11-30 | 2020-07-22 | Case Western Reserve University | Combinations of 15-pgdh inhibitors with corcosteroids and/or tnf inhibitors and uses thereof |
WO2018145080A1 (en) | 2017-02-06 | 2018-08-09 | Case Western Reserve University | Compositions and methods of modulating short-chain dehydrogenase activity |
KR102633530B1 (en) * | 2017-03-31 | 2024-02-02 | 오리진 온콜로지 리미티드 | Compounds and compositions for treating blood disorders |
CN107954977A (en) * | 2017-12-15 | 2018-04-24 | 上海鼎雅药物化学科技有限公司 | The synthetic method of Raltitrexed intermediate |
WO2020047198A1 (en) | 2018-08-31 | 2020-03-05 | Incyte Corporation | Salts of an lsd1 inhibitor and processes for preparing the same |
TW202304911A (en) * | 2021-04-23 | 2023-02-01 | 大陸商南京明德新藥研發有限公司 | Pyridinamide compound |
WO2023169438A1 (en) * | 2022-03-07 | 2023-09-14 | 上海凌达生物医药有限公司 | Nitrogen-containing heterocyclic cell cycle inhibitor compounds as well as preparation method therefor and use thereof |
WO2024088192A1 (en) * | 2022-10-26 | 2024-05-02 | Js Innopharm (Suzhou) Ltd. | An aurora a inhibitor for use in treatments of cancers |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004026877A1 (en) * | 2002-09-23 | 2004-04-01 | Schering Corporation | Imidazopyrazines as cyclin dependent kinase inhibitors |
WO2006053121A2 (en) * | 2004-11-10 | 2006-05-18 | Cgi Pharmaceuticals, Inc. | Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity |
WO2007058873A2 (en) * | 2005-11-10 | 2007-05-24 | Schering Corporation | Imidazopyrazines as cyclin depentend kinase inhibitors |
WO2007058942A2 (en) * | 2005-11-10 | 2007-05-24 | Schering Corporation | Imidazopyrazines as protein kinase inhibitors |
-
2008
- 2008-06-11 EP EP08768351A patent/EP2170892A2/en not_active Withdrawn
- 2008-06-11 CN CN200880101960A patent/CN101772500A/en active Pending
- 2008-06-11 CA CA2690557A patent/CA2690557A1/en not_active Abandoned
- 2008-06-11 JP JP2010512177A patent/JP2010529195A/en not_active Withdrawn
- 2008-06-11 WO PCT/US2008/007295 patent/WO2008156614A2/en active Application Filing
- 2008-06-11 MX MX2009013729A patent/MX2009013729A/en not_active Application Discontinuation
- 2008-06-11 AR ARP080102481A patent/AR066958A1/en not_active Application Discontinuation
- 2008-06-11 PE PE2008001001A patent/PE20090365A1/en not_active Application Discontinuation
- 2008-06-12 TW TW097121942A patent/TW200911811A/en unknown
- 2008-06-12 CL CL2008001745A patent/CL2008001745A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004026877A1 (en) * | 2002-09-23 | 2004-04-01 | Schering Corporation | Imidazopyrazines as cyclin dependent kinase inhibitors |
WO2006053121A2 (en) * | 2004-11-10 | 2006-05-18 | Cgi Pharmaceuticals, Inc. | Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity |
WO2007058873A2 (en) * | 2005-11-10 | 2007-05-24 | Schering Corporation | Imidazopyrazines as cyclin depentend kinase inhibitors |
WO2007058942A2 (en) * | 2005-11-10 | 2007-05-24 | Schering Corporation | Imidazopyrazines as protein kinase inhibitors |
Also Published As
Publication number | Publication date |
---|---|
EP2170892A2 (en) | 2010-04-07 |
CA2690557A1 (en) | 2008-12-24 |
AR066958A1 (en) | 2009-09-23 |
WO2008156614A2 (en) | 2008-12-24 |
MX2009013729A (en) | 2010-01-25 |
CN101772500A (en) | 2010-07-07 |
JP2010529195A (en) | 2010-08-26 |
PE20090365A1 (en) | 2009-04-04 |
CL2008001745A1 (en) | 2008-12-05 |
TW200911811A (en) | 2009-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008156614A3 (en) | Imidazopyrazines as protein kinase inhibitors | |
WO2007058942A3 (en) | Imidazopyrazines as protein kinase inhibitors | |
WO2010088368A3 (en) | Imidazopyrazines as protein kinase inhibitors | |
WO2008057512A3 (en) | Imidazopyrazines as protein kinase inhibitors | |
WO2007044426A3 (en) | Pyrazolopyrimidines as protein kinase inhibitors | |
TW200745128A (en) | Pyrazolopyrimidines as protein kinase inhibitors | |
WO2007058873A3 (en) | Imidazopyrazines as cyclin depentend kinase inhibitors | |
TW200745123A (en) | Pyrazolopyrimidines as protein kinase inhibitors | |
WO2008045266A3 (en) | Pyrazolopyrimidiwes as cyclin dependent kinase inhibitor | |
WO2007044449A3 (en) | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
WO2007044401A3 (en) | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
MX2009011355A (en) | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors. | |
WO2008045268A3 (en) | Pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
WO2008045267A3 (en) | Pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
WO2005077954A3 (en) | Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors | |
WO2007079164A3 (en) | Protein kinase inhibitors | |
HK1112233A1 (en) | Pyrazolopyrimidines as cyclin dependent kinase inhibitors for the treatment of cancer | |
HK1116349A1 (en) | Pyrrolopyrimidines useful as inhibitors of protein kinase | |
GEP20115283B (en) | Pyrrolopyrimidine compounds and their uses | |
WO2007011962A3 (en) | Treatment of cancer | |
WO2007084557A3 (en) | Azaindoles useful as inhibitors of janus kinases | |
WO2007076423A3 (en) | INHIBITORS OF Akt ACTIVITY | |
WO2005116025A3 (en) | 2-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disorders | |
WO2008079521A3 (en) | Tricyclic heteroaryl compounds useful as inhibitors of janus kinase | |
WO2005103050A3 (en) | Azaindoles useful as inhibitors of rock and other protein kinases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880101960.X Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08768351 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2690557 Country of ref document: CA Ref document number: 2010512177 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2009/013729 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008768351 Country of ref document: EP |